FDA has revised its proposal for rapidly communicating updated standards to device firms in new draft standard operating procedures. In particular, the agency has dropped the previously proposed “notice-to-industry letter” terminology and abandoned the idea of conducting such rapid-fire communications in anything but official guidance format.
Issued Sept. 5, the draft SOP describes the device center’s planned approach to creating and issuing “Level 1...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?